Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening

Hüzmeli, can; YILMAZ, ALİ; GÖKÇEN, PINAR; YILMAZ, Hatice; Yılmaz, Abdulkerim

doi:10.5152/eurasianjmed.2021.20412

Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening

Ali YILMAZ, (Cumhuriyet Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Sivas, Türkiye)

Pınar GÖKÇEN, (Cumhuriyet Üniversitesi, Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, Sivas, Türkiye)

Hatice YILMAZ, (Tire Devlet Hastanesi, İç Hastalıkları Anabilim Dalı, İzmir, Türkiye)

Can HÜZMELİ, (Cumhuriyet Üniversitesi, Tıp Fakültesi, Nefroloji Anabilim Dalı, Sivas, Türkiye)

Abdülkerim YILMAZ (Cumhuriyet Üniversitesi, Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, Sivas, Türkiye)

Eurasian Journal of Medicine

1 0

Yıl: 2021 Cilt: 53 Sayı: 3 Sayfa Aralığı: 220 - 226 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2021.20412 İndeks Tarihi: 01-01-2022

Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening

Öz:

Objective: Irritable bowel syndrome (IBS) is a frequently seen functional bowel disease. Although not lifethreatening, it impairs quality of life and leads to economic losses. IBS symptoms are widespread in dialysis patients. Psychopathological disorders are known to increase in both IBS and dialysis patients. The purpose of this study was to investigate the prevalence of IBS, IBS-related factors, and psychopathological disorders in patients. Materials and Methods: One hundred fifty patients followed-up in hemodialysis (HD) or peritoneal dialysis (PD) programs were included in this prospective study. Patients were divided into groups with and without diagnoses of IBS based on the Rome-III diagnostic criteria. The Symptom Check List Revised (SCL90-R) test was then applied to the patients. Patients with and without IBS were compared according to the scores obtained from the questionnaire. Results: IBS was determined in 59 (39.3%) of the dialysis patients. The prevalence of IBS was significantly higher in women (P = .030). The presence of coronary artery disease (CAD) and use of erythropoietin (EPO) were significantly higher in patients with IBS (P = .029, P = .031). Somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety, phobic anxiety, psychoticism, and additional items were also higher in patients with IBS. Subscale scores for somatization, depression, and additional parameters in dialysis patients with IBS were above the threshold values for screening. Conclusion: IBS is common in dialysis patients. The presence of CAD or use of EPO were frequently observed in dialysis patients with IBS, and psychopathologies in depression, somatization, and additional subparameters were also higher in these patients.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology. 1997;112(6):2120-2137. [Crossref]
2. Karaman N, Türkay C, Yönem Ö. Irritable bowel syndrome prevalance in city center of Sivas. Turk J Gastroenterol. 2003;14:128-131. 14614640
3. Yılmaz S, Dursun M, Ertem M, Canoruc F, Turhanoglu A. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: A stratified randomised community-based study. Int J Clin Pract. 2005;59:361-369. [Crossref]
4. Drossman D. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390. [Crossref]
5. Whitehead WE, Drossman DA. Validation of symptom-based diagnostic criteria for irritable bowel syndrome: A critical review. Am J Gastroenterol. 2010;105(4):814-820. [Crossref]
6. Helvaci MR, Algin MC, Kaya H. Irritable bowel syndrome and chronic gastritis, hemorrhoid, urolithiasis. Eurasian J Med. 2009;41 (3):158-161. 25610094
7. Drossman DA, Creed FH, Olden KW, Svedlund J, Toner B, Whitehead W. Psychosocial aspects of the functional gastrointestinal disorders. Gut. 1999;45(Suppl 2):1125-1130. [Crossref]
8. Derogatis LR. SCL 90 R Administration, Scoring and Procedures Manual II for the Revised Version and Other Instruments of the Psychopathology Rating Scale Series. Clinical Psychometric Research, 1986.
9. Chan R, Brooks R, Erlich J, Chow J, Suranyi M. The effects of kidney disease-related loss on long-term dialysis patients’ depression and quality of life: Positive affect as a mediator. Clin J Am Soc Nephrol. 2009;4:160-167. [Crossref]
10. Guven S, Sari F, Inci A, Cetinkaya R. Sexual dysfunction is associated with depression and anxiety in patients with predialytic chronic kidney disease. Eurasian J Med. 2018;50(2):75-80. [Crossref]
11. Cano AE, Neil AK, Kang JY, et al. Gastrointestinal symptoms in patients with end-stage renal disease undergoing treatment by hemodialysis or peritoneal dialysis. Am J Gastroenterol. 2007;102:1990-1997. [Crossref]
12. Kahvecioglu S, Akdag I, Kiyici M, et al. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure. J Nephrol. 2005;18:61-66. 15772924
13. Mayer EA, Craske MG, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry. 2001;62(Suppl 8):28-36. 12108819
14. Alvarez-Ude F, Fernandez-Reyes MJ, Vazquez A, Mon C, Sanchez R, Rebollo P. Physical symptoms and emotional disorders in patient on a periodic hemodialysis program. Nefrologia. 2001;21:191- 199. 11464653
15. American Gastroenterological Association. American gastroenterological association medical position statement: Irritable bowel syndrome. Gastroenterology. 2002;123:2105-2107. [Crossref]
16. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125:1651-1659. [Crossref]
17. Boyce PM, Koloskı NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: Are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterology. 2000;95 (11):3176-3183. [Crossref]
18. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 (Suppl 2):1-9. [Crossref]
19. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: Prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21:1365-1375. [Crossref]
20. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: Results from a large web-based survey. Aliment Pharmacol Ther. 2005;22:935-942. [Crossref]
21. Afsar B, Elsurer R, Yılmaz MI, Eyileten T, Yenicesu M. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression nephrology. Nephrology 2010;15:197-202 .[Crossref]
22. Çelebi S, Acik Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in A Turkish Urban Society. J Gastroenterol Hepatol. 2004;19:738. [Crossref]
23. Fiderkiewicz B, Rosołowska AR, Myśliwiec M, et al. Factors associated with irritable bowel syndrome symptoms in hemodialysis patients. World J Gastroenterol. 2011;17(15):1976-1981. [Crossref]
24. Kim YJ, Ban DJ. Prevalence of irritable bowel syndrome, influence of lifestyle factors and bowel habits in Korean College Students. Int J Nurs Stud. 2005;42(3):247-254. [Crossref]
25. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalance of irritable bowel syndrome: A community survey. Br J Gen Pract. 2004;54 (504) :495-502. 15239910
26. Park KS, Ahn SH, Hwang JS, et al. A survey about irritable bowel syndrome in South Korea: prevalence and observable organic abnormalities in ibs patients. Dig Dis Sci. 2008;53:704-711. [Crossref]
27. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep. 2003;26:747-752. [Crossref]
28. Gök EG, İnci A, Çoban M, Kutsal DA, Kürşat S. Functional bowel disorders and associated risk factors in hemodialysis patients in Turkey. Turk J Gastroenterol. 2017;28:129. [Crossref]
29. Chen CH, Lin CL, Kao CH. Irritable bowel syndrome is associated with an increased risk of dementia: A nationwide population-based study. PLoS One. 2016;5:11(1). [Crossref]
30. Ciftci O, Yilmaz KC, Karacaglar E, Yilmaz M, Ozin B, Muderrisoglu IH. The Novel CHA 2 DS 2-VASC-FSH score is predictive of severe coronary artery disease on coronary angiography in patients with atrial fibrillation and unstable symptoms. Eurasian J Med. 2019;51(2):165-171. [Crossref]
31. Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand P. Comorbidity of irritable bowel syndrome in psychiatric patients: A review. Am J Ther. 2003;10:61-67. [Crossref]
32. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with Ibs: A prevalence study. Bmc Gastroenterol. 2006;6:26-33. [Crossref]
33. Kabra N, Nadkarnı A. Prevalence of depression and anxiety in irritable bowel syndrome: A clinic based study from India. Indian J Psychiatry. 2013;55(1):77-80. [Crossref]
34. Gralnek IM, Hays RD, Kılbourne A, et al. The impact of irritable bowel syndrome on health– related quality of life. Gastroenterelogy. 2000;119:654-660. [Crossref]

APA	YILMAZ A, GÖKÇEN P, YILMAZ H, Hüzmeli c, Yılmaz A (2021). Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. , 220 - 226. 10.5152/eurasianjmed.2021.20412
Chicago	YILMAZ ALİ,GÖKÇEN PINAR,YILMAZ Hatice,Hüzmeli can,Yılmaz Abdulkerim Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. (2021): 220 - 226. 10.5152/eurasianjmed.2021.20412
MLA	YILMAZ ALİ,GÖKÇEN PINAR,YILMAZ Hatice,Hüzmeli can,Yılmaz Abdulkerim Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. , 2021, ss.220 - 226. 10.5152/eurasianjmed.2021.20412
AMA	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. . 2021; 220 - 226. 10.5152/eurasianjmed.2021.20412
Vancouver	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. . 2021; 220 - 226. 10.5152/eurasianjmed.2021.20412
IEEE	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A "Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening." , ss.220 - 226, 2021. 10.5152/eurasianjmed.2021.20412
ISNAD	YILMAZ, ALİ vd. "Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening". (2021), 220-226. https://doi.org/10.5152/eurasianjmed.2021.20412

APA	YILMAZ A, GÖKÇEN P, YILMAZ H, Hüzmeli c, Yılmaz A (2021). Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. Eurasian Journal of Medicine, 53(3), 220 - 226. 10.5152/eurasianjmed.2021.20412
Chicago	YILMAZ ALİ,GÖKÇEN PINAR,YILMAZ Hatice,Hüzmeli can,Yılmaz Abdulkerim Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. Eurasian Journal of Medicine 53, no.3 (2021): 220 - 226. 10.5152/eurasianjmed.2021.20412
MLA	YILMAZ ALİ,GÖKÇEN PINAR,YILMAZ Hatice,Hüzmeli can,Yılmaz Abdulkerim Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. Eurasian Journal of Medicine, vol.53, no.3, 2021, ss.220 - 226. 10.5152/eurasianjmed.2021.20412
AMA	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. Eurasian Journal of Medicine. 2021; 53(3): 220 - 226. 10.5152/eurasianjmed.2021.20412
Vancouver	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening. Eurasian Journal of Medicine. 2021; 53(3): 220 - 226. 10.5152/eurasianjmed.2021.20412
IEEE	YILMAZ A,GÖKÇEN P,YILMAZ H,Hüzmeli c,Yılmaz A "Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening." Eurasian Journal of Medicine, 53, ss.220 - 226, 2021. 10.5152/eurasianjmed.2021.20412
ISNAD	YILMAZ, ALİ vd. "Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening". Eurasian Journal of Medicine 53/3 (2021), 220-226. https://doi.org/10.5152/eurasianjmed.2021.20412